Quality assurance for interventions in clinical trials: Multicenter data monitoring, data management, and analysis

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Quality assurance for the management of multicenter clinical trials requires timely patient and data accrual and consistency with design parameters. Data from central pathology review, treatment modality, and follow‐up as well as trial end points direct the selection of appropriate compliance measures. To integrate these data to monitor group performance on a specific protocol, to monitor discipline performance, or to monitor an institution's performance is a formidable task. This is especially true for a group such as the Pediatric Oncology Group, where there are a large number of protocols, many diseases, and widely differing protocol requirements. Quality assurance methods for the Pediatric Oncology Group are discussed.

Original languageEnglish (US)
Pages (from-to)2647-2652
Number of pages6
JournalCancer
Volume74
Issue number9 S
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Clinical Trials
Pediatrics
Compliance
Multicenter Studies
Pathology
Therapeutics

Keywords

  • clinical trials
  • data monitoring
  • performance evaluation
  • quality assurance

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Quality assurance for interventions in clinical trials : Multicenter data monitoring, data management, and analysis. / Pollock, Bradley H.

In: Cancer, Vol. 74, No. 9 S, 1994, p. 2647-2652.

Research output: Contribution to journalArticle

@article{2811c61dba6b435c9122d347e135f139,
title = "Quality assurance for interventions in clinical trials: Multicenter data monitoring, data management, and analysis",
abstract = "Quality assurance for the management of multicenter clinical trials requires timely patient and data accrual and consistency with design parameters. Data from central pathology review, treatment modality, and follow‐up as well as trial end points direct the selection of appropriate compliance measures. To integrate these data to monitor group performance on a specific protocol, to monitor discipline performance, or to monitor an institution's performance is a formidable task. This is especially true for a group such as the Pediatric Oncology Group, where there are a large number of protocols, many diseases, and widely differing protocol requirements. Quality assurance methods for the Pediatric Oncology Group are discussed.",
keywords = "clinical trials, data monitoring, performance evaluation, quality assurance",
author = "Pollock, {Bradley H}",
year = "1994",
doi = "10.1002/1097-0142(19941101)74:9+<2647::AID-CNCR2820741811>3.0.CO;2-X",
language = "English (US)",
volume = "74",
pages = "2647--2652",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "9 S",

}

TY - JOUR

T1 - Quality assurance for interventions in clinical trials

T2 - Multicenter data monitoring, data management, and analysis

AU - Pollock, Bradley H

PY - 1994

Y1 - 1994

N2 - Quality assurance for the management of multicenter clinical trials requires timely patient and data accrual and consistency with design parameters. Data from central pathology review, treatment modality, and follow‐up as well as trial end points direct the selection of appropriate compliance measures. To integrate these data to monitor group performance on a specific protocol, to monitor discipline performance, or to monitor an institution's performance is a formidable task. This is especially true for a group such as the Pediatric Oncology Group, where there are a large number of protocols, many diseases, and widely differing protocol requirements. Quality assurance methods for the Pediatric Oncology Group are discussed.

AB - Quality assurance for the management of multicenter clinical trials requires timely patient and data accrual and consistency with design parameters. Data from central pathology review, treatment modality, and follow‐up as well as trial end points direct the selection of appropriate compliance measures. To integrate these data to monitor group performance on a specific protocol, to monitor discipline performance, or to monitor an institution's performance is a formidable task. This is especially true for a group such as the Pediatric Oncology Group, where there are a large number of protocols, many diseases, and widely differing protocol requirements. Quality assurance methods for the Pediatric Oncology Group are discussed.

KW - clinical trials

KW - data monitoring

KW - performance evaluation

KW - quality assurance

UR - http://www.scopus.com/inward/record.url?scp=0028020593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028020593&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19941101)74:9+<2647::AID-CNCR2820741811>3.0.CO;2-X

DO - 10.1002/1097-0142(19941101)74:9+<2647::AID-CNCR2820741811>3.0.CO;2-X

M3 - Article

C2 - 7954280

AN - SCOPUS:0028020593

VL - 74

SP - 2647

EP - 2652

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 9 S

ER -